Phosphatidylserine, Dementia, Cognitive Decline Health Claim Sought
This article was originally published in The Tan Sheet
Executive Summary
No particular dose of phosphatidylserine works better at reducing the severity of cognitive dysfunction and the risk of dementia, according to a health claim petition filed with FDA April 19
You may also be interested in...
Selenium Cancer Risk Reduction Qualified Claims To Be Allowed By FDA
Health claims linking selenium supplements with reducing cancer risk will be permitted by FDA through its "enforcement discretion," according to the agency
Selenium Cancer Risk Reduction Qualified Claims To Be Allowed By FDA
Health claims linking selenium supplements with reducing cancer risk will be permitted by FDA through its "enforcement discretion," according to the agency
Selenium Cancer Risk Reduction Qualified Claims To Be Allowed By FDA
Health claims linking selenium supplements with reducing cancer risk will be permitted by FDA through its "enforcement discretion," according to the agency